ReferenceID 4734
Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation
J Ethnopharmacol
Ethnopharmacological relevance: Hypericum japonicum Thunb. ex Murray (Hypericaceae), named 'Tianjihuang' is a traditional Chinese medicine with hepatoprotective, antibacterial, and antitumour effects. Betulinic acid (BA)
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 4734
- Evidence Id
- 21324
- Core Evidence Id
- 21324
- Source Reference Id
- 2711
- Herb2 Reference Id
- HBREF003508
- Subject Paper Key
- HBIN018373_35714879
- Pubmed Id
- 35714879
- Doi
- 10.1016/j.jep.2022.115459
- Paper Title
- Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation
- Paper Abstract
- Ethnopharmacological relevance: Hypericum japonicum Thunb. ex Murray (Hypericaceae), named 'Tianjihuang' is a traditional Chinese medicine with hepatoprotective, antibacterial, and antitumour effects. Betulinic acid (BA) is its active constituent and has been found to have a number of biological effects, including antiviral, anti-inflammatory, and anti-malarial therapeutic properties. Non-alcoholic fatty liver disease and acute alcoholic liver injury have both been proven to benefit from BA. BA's effects and mechanism on liver fibrosis are still unknown. Aim of the study: The purpose of this study was to explore the influence of BA on lymphocyte-specific protein tyrosine kinase (Lck), a non-receptor Src family kinase, that reduces liver fibrosis by inhibiting the phosphorylation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways through the interaction of Lck and SOCS1. Materials and methods: A liver fibrosis model was established in vivo with CCl 4 using haematoxylin and eosin (HE) staining, Masson staining, immunohistochemical staining, and immunofluorescence staining. Hepatic stellate cells were induced with transforming growth factor (TGF)-β1 in vitro, using Western blotting, immunofluorescence staining, and a cell scratch assay. Results: In a CCl 4 -induced mouse hepatic fibrosis model and in TGF-β1-activated HSC-T6 cells, BA markedly reduced fibrosis, as demonstrated by the dramatic downregulation of α-smooth muscle actin (α-SMA) and type I collagen alpha-1 (Col1α1) protein levels in vivo and in vitro. BA significantly suppressed the activity and expression of Lck in vitro. Overexpression of Lck may diminish the effect of BA on liver fibrosis. In vitro, BA also greatly increased the expression of suppressor of cytokine signalling 1 (SOCS1) while it considerably inhibited the expression of p-JAK and p-STAT1. Conclusions: These findings suggest that BA promotes the expression of SOCS1 by the inhibiting the interaction between Lck and SOCS1, followed by the inhibition of JAK/STAT phosphorylation to prevent the progression of liver fibrosis. Therefore, BA could be used as a promising natural supplement for the treatment of liver fibrosis.
- Journal
- J Ethnopharmacol
- Publish Year
- 2022
- Experiment Subject
- mouse; ccl 4; tgf-β1-activated hsc-t6 cells
- Experiment Type
- Animal & Cell Experiment
- Phenotype Related
- Fibrosis; Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Acute Alcoholic Liver Injury; Hepatic Fibrosis
- Paper Title Cn
- Paper Title En
- Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation
- Bilingual Status
- semi_complete